Financial Performance - For FY2023/2024, the profit attributable to equity shareholders grew by 155% to HK$116 million, driven by improved sales execution in Mainland China and product innovation in Hong Kong[15]. - Group revenue for FY2023/2024 was HK$6,217 million, representing a 1% increase over the previous year, with a 10% revenue growth in Mainland China in the second half offsetting a 3% decline in the first half[15]. - Gross profit increased by 3% to HK$3,111 million, while EBITDA rose by 10% to HK$685 million[8]. - Basic earnings per share increased by 153% to 10.9 HK cents, compared to 4.3 HK cents in the previous year[8]. - The total dividend for FY2023/2024 is proposed at 7.7 HK cents per ordinary share, which includes a final dividend of 6.3 HK cents and an interim dividend of 1.4 HK cents[16]. - Total assets decreased by 4% to HK$5,637 million as of March 31, 2024[11]. - The net cash balance improved to HK$111 million, compared to a net debt of HK$197 million in the previous year[11]. - Total equity attributable to equity shareholders increased by 1% to HK$3,005 million[11]. - Profit from operations grew significantly by 79% in FY2023/2024, attributed to a higher gross profit margin and greater efficiencies following rightsizing of investments and expenses[29]. - Gross profit margin rose to 50%, mainly due to higher selling prices and increased efficiency in trade promotional spending[29]. Regional Performance - In Mainland China, revenue increased by 10% in local currency terms during the second half of the year, with both VITASOY and VITA brands returning to growth[28]. - The Hong Kong Operation achieved robust single-digit growth through strong core portfolio performance and selective product innovation[28]. - Revenue from external customers in Mainland China was RMB 3,087 million, showing no change year-on-year, while profit from operations increased by 402% to RMB 203 million[60]. - Revenue from external customers in HK$ was HK$3,359 million, a decrease of 4% from HK$3,509 million in the previous year[60]. - In Australia and New Zealand, revenue from external customers decreased to HK$527 million, a decline of 9% due to out-of-stock situations and logistics issues[65]. Strategic Initiatives - The company aims to continue growing its business and improving structural profitability in the coming year[27]. - New product offerings are being expanded in Mainland China and Hong Kong to appeal to different consumer segments[30]. - The company is well-positioned to capitalize on the growing demand for plant-based beverages[14]. - The company aims to improve revenue and profit growth in Mainland China, leveraging the long-term growth potential of the plant-based movement[72]. - The Hong Kong operation plans to sustain growth by strengthening core products and introducing innovative offerings under the VITASOY and VITA brands[74]. Sustainability and Governance - The company retained its grade A rating in the MSCI ESG ratings and was featured in Corporate Knights' Global 100 Most Sustainable Corporations for the fifth consecutive year[41]. - The company is committed to reducing water intensity in production and aims for zero manufacturing waste to landfill by FY2025/2026[36]. - The company has engaged with top suppliers to improve carbon data for Scope 3 emissions and conducted ESG risk mapping for key commodities[40]. - The Company emphasizes the integration of ESG considerations into its strategic plans, reflecting a proactive approach to macro-economic and regulatory changes[96]. - The Board has established various committees to carry out specialized functions, ensuring effective governance and oversight[92]. Board Composition and Diversity - The board consists of 11 directors, with 5 being independent non-executive directors and 2 being female[85]. - The Company aims to maintain female representation on the Board at "not less than 18%" and will review this target over time[108]. - The overall gender diversity of the Company's workforce for FY2023/2024 is approximately 48% female and 52% male[110]. - The Board Diversity Policy aims to achieve diversity through factors such as experience, professional qualification, gender, and ethnicity, with annual reviews for compliance and effectiveness[102][103]. Risk Management and Internal Control - The Company acknowledges its responsibility for risk management and internal control systems, ensuring they provide reasonable assurance against material misstatement[189]. - The internal control system is designed to manage business risks rather than eliminate them, based on COSO principles[193]. - The Company has established a whistleblowing system to enhance communication regarding ethics and integrity standards[200]. - The Audit Committee is responsible for reviewing the internal control system of anti-corruption[151]. Training and Development - The average training hours for Directors during FY2023/2024 was 75 hours, indicating a commitment to continuous professional development[167]. - The average training hours of Senior Management during FY2023/2024 was 60 hours, emphasizing the importance of continuous professional development[173]. - The Company encourages Senior Management to participate in various continuous professional development programs at the Company's expense[174].

Financial Performance - For the fiscal year ending March 31, 2024, the company's revenue was HKD 6,217 million, a decrease of 2% compared to HKD 6,341 million in the previous year, but a growth of 1% after excluding currency effects[2]. - The gross profit increased by 3% to HKD 3,111 million, with a gross margin of 50.0%, up from 47.5% in the previous year, reflecting a 2.5 percentage point increase[2][3]. - Operating profit surged by 79% to HKD 185 million, with EBITDA rising by 10% to HKD 685 million, indicating a strong operational performance[2][3]. - The profit attributable to equity holders of the company increased significantly by 155% to HKD 116 million, driven by improved sales strategies in mainland China and product innovation in Hong Kong[3]. - The overall comprehensive income for the year was HKD 13 million, a significant recovery from a loss of HKD 182 million in the previous year[6]. - The pre-tax profit for the year was HKD 116,367,000, compared to HKD 45,721,000 in the previous year, representing a significant increase[27]. - The basic earnings per share increased to HKD 0.108 from HKD 0.043 year-on-year, reflecting a growth of approximately 151%[27]. Cash Flow and Assets - Cash and bank deposits (excluding bank loans) rose from HKD 30 million to HKD 538 million, reflecting improved cash flow and reduced capital expenditures[3]. - The company's cash and bank deposits as of March 31, 2024, were HKD 794,452,000, compared to HKD 555,292,000 in the previous year, marking an increase of approximately 43%[7]. - Total assets as of March 31, 2024, amounted to HKD 3,411,319,000, compared to HKD 3,377,597,000 in the previous year, reflecting an increase of approximately 1%[7]. - The company's net assets increased to HKD 3,112,637,000 in 2024 from HKD 3,100,590,000 in 2023, representing a growth of about 0.4%[8]. - The total equity attributable to equity holders of the company rose to HKD 3,004,560,000 in 2024, up from HKD 2,984,715,000 in 2023, indicating an increase of approximately 0.7%[8]. - Current liabilities decreased from HKD 2,471,922,000 in 2023 to HKD 2,225,376,000 in 2024, a reduction of about 10%[7]. - The company's bank loans decreased from HKD 409,633,000 in 2023 to HKD 255,987,000 in 2024, a decline of approximately 37%[7]. - The company's total reserves decreased slightly from HKD 1,963,262,000 in 2023 to HKD 1,960,162,000 in 2024, a decrease of about 0.2%[8]. Dividends and Shareholder Returns - The board proposed a final dividend of HKD 0.063 per share, totaling HKD 0.077 per share for the fiscal year, compared to HKD 0.027 per share in the previous fiscal year[3]. - The total dividend proposed for the year is HKD 82,591,000, which includes an interim dividend of HKD 15,004,000 and a final dividend of HKD 67,587,000[25]. Operational Highlights - Mainland China revenue showed a robust recovery in the second half of the fiscal year, with operating profit increasing by 402% in local currency[3]. - The company's performance in Hong Kong remained strong, with operating profit growth of 42% after excluding COVID-19 related government subsidies[3]. - The company is currently addressing production compliance issues in Australia, which have impacted performance[3]. - The company faced challenges in its Australia and New Zealand operations due to production targets, price competition, and high logistics costs, impacting performance[41]. - In Southeast Asia, Singapore's revenue remained flat year-on-year, while the Philippines joint venture saw strong growth in household products and convenience store platforms[41]. - The company plans to continue expanding its market presence and investing in new technologies[21]. - New product launches and marketing activities are planned to drive continuous growth in the Hong Kong market[55]. - The company aims to restore profitability in Singapore by improving tofu and export sales in collaboration with new distributors[56]. Compliance and Risk Management - The company has not applied any new standards or interpretations that have not yet come into effect during the reporting period, ensuring consistency in accounting policies[10]. - The company emphasizes compliance with tax laws and transparency in tax matters, adhering to OECD transfer pricing guidelines[60]. - The company has implemented a comprehensive risk management framework to identify and mitigate key business risks[62]. Future Outlook - The company plans to optimize production at Vitasoy (Shanghai) by temporarily halting production and maintaining the factory for future operations[37]. - The company plans to expand its business scale and enhance profitability in mainland China for the fiscal year 2024/2025[54].

Financial Performance - Revenue for the interim period decreased by 7% to HK$3,391 million compared to HK$3,642 million in the previous year[7]. - Profit from operations fell by 19% to HK$171 million, down from HK$212 million[7]. - EBITDA decreased by 11% to HK$422 million from HK$473 million[7]. - Profit before taxation decreased by 10% to HK$158 million, but grew by 39% when excluding currency impact and COVID-19-related subsidies[32]. - Profit attributable to equity shareholders increased by 15% to HK$163 million, compared to HK$142 million last year[7]. - The Group's gross profit for the interim period was HK$1,712 million, a decrease of 1% from HK$1,738 million in the previous interim period[27][30]. - The total comprehensive income for the period was HK$162,681,000, a decrease from HK$49,232,000 in the previous year, reflecting a significant change in financial performance[89]. Revenue Breakdown - Revenue from Mainland China decreased by 6% in local currency terms, with profit from operations growing by 44% in local currency[13]. - The Hong Kong operation saw a revenue increase of 4%, driven by product innovations like VITAOAT Oat Milk and VITA Sparkling Tea[14]. - Australia and New Zealand experienced a revenue decrease of 10% in local currency, resulting in a loss from operations due to manufacturing and logistics challenges[14]. - Revenue from Mainland China decreased by 6% in local currency and 11% in Hong Kong Dollar terms, primarily due to advanced orders placed before a price increase and increased market competition[20][24]. - Revenue from Australia and New Zealand decreased by 10% in local currency and 16% in Hong Kong Dollar terms, attributed to temporary manufacturing issues and logistics challenges[16][22]. - Revenue from Singapore increased by 1% to SGD 9,096 thousand, with a 19% improvement in exports offset by weaker beverage sales[52]. Cost and Expenses - Total operating expenses remained stable at HK$1,581 million, with marketing and distribution expenses managed at HK$1,073 million[28][31]. - Administrative expenses increased by 4% to HK$348 million, primarily due to higher costs in the Australia business after the cessation of prior administrative support[28][31]. - The Group's cash flow hedge net movement of (HK$1,748,000), an improvement from (HK$3,424,000) in the previous year[80]. - Total other operating expenses decreased to HK$160,920,000 from HK$186,677,000, a reduction of approximately 13.8%[130]. Cash and Liquidity - Net cash balance improved to HK$156 million from a net debt of HK$197 million[7]. - Cash and bank deposits amounted to HK$710 million as of 30th September 2023, an increase from HK$555 million on 31st March 2023[33]. - The Group's total current liabilities decreased from $524,686,000 as of 31st March 2023 to $237,450,000 as of 30th September 2023[164]. - The Group's cash at bank and in hand decreased to $249,234,000 as of September 30, 2023, from $259,778,000 as of March 31, 2023, a decline of approximately 4.4%[156]. Shareholder Returns - The Board of Directors declared an interim dividend of HK1.4 cents per ordinary share, up from HK1.3 cents in the previous interim period[17]. - The interim dividend declared after 30th September 2023 is 1.4 cents per ordinary share, an increase from 1.3 cents in the previous interim period, totaling $15,019,000[168]. - The company paid dividends of HK$14,975,000 to equity shareholders, reflecting a commitment to returning value to shareholders[91]. Strategic Initiatives - The company plans to focus on improving sales execution and restoring revenue growth while containing costs in the second half of the financial year[53]. - The company is confident in the growth potential of sustainable plant-based food and beverages and aims to expand core products strategically[54]. - The organizational redesign has created synergy across functional teams, enhancing local capabilities[43]. - The company is committed to providing a safe, healthy, and inclusive workplace, with initiatives like safety awareness training and a Women Leaders Networking Group[65]. Employee Engagement - As of September 30, 2023, Vitasoy had a total of 6,534 employees, with a gender ratio of 48% female and a lost-time injury rate of 0.64[66]. - During the interim period, employees spent approximately 35,235 hours in learning and development activities to enhance skills[65]. - A Sustainable Engagement Score of 85% was achieved, outperforming global food and beverage companies by 2%[64]. Tax and Compliance - The company is committed to transparency with tax authorities and compliance with tax laws across all relevant jurisdictions[36]. - Current tax expense for Hong Kong Profits Tax was $12,464,000, up from $6,152,000 in the previous period, indicating a significant increase of 102.5%[133]. - The company experienced a deferred tax credit of $(38,749,000), contrasting with a deferred tax expense of $22,616,000 in the previous interim period, highlighting a substantial change in tax position[133]. Market Position and Community Engagement - The company maintained leadership in the ready-to-drink soymilk and tea categories in Hong Kong, according to Nielsen retail audit[46]. - The company distributed approximately 1.6 million packs of Low Sugar Soyabean Milk to over 6,000 students from 42 primary schools as part of its community care project[68]. - Vitasoy has been a principal sponsor of the CafeSmart initiative for four consecutive years, supporting charities to combat homelessness in Australia[73].

Revenue and Profitability - Revenue for the six months ended September 30, 2023, was HKD 3,391 million, a decrease of 7% compared to HKD 3,642 million in the same period last year[2]. - Total revenue for the six months ended September 30, 2023, was HKD 3,490,702,000, a decrease of 6.4% compared to HKD 3,729,632,000 for the same period in 2022[13]. - Revenue from external customers in Mainland China was HKD 1,962,039,000, down 11.5% from HKD 2,215,748,000 in the previous year[13]. - Revenue in mainland China decreased by 6% to RMB 1,798,000,000, while operating profit grew by 44% with an operating margin of 10%[46]. - Revenue from the Hong Kong business increased by 4%, driven by strong performance in core products and innovations like VITAOAT oat milk[32]. - Revenue from Australia and New Zealand decreased by 10% in local currency and 16% in HKD, with a reported operating loss of HKD 33,000,000 due to high costs and supply chain issues[48]. - Singapore revenue increased by 1% in local currency and 4% in HKD, with export business growing by 19% despite challenges in the beverage sector[49]. Profit and Earnings - Gross profit was HKD 1,712 million, down 1% from HKD 1,738 million, with a gross margin increase to 50.5% from 47.7%[2][3]. - Operating profit decreased by 19% to HKD 171 million, but increased by 15% when excluding the impact of foreign exchange and government subsidies[3]. - Profit attributable to equity holders increased by 15% to HKD 163 million, with a significant 99% increase when adjusted for prior year subsidies[3]. - Basic earnings per share for the six months ended September 30, 2023, were HKD 162,681, an increase of 14.7% from HKD 141,801 in the same period of 2022[21]. - The diluted earnings per share increased to HKD 0.151 from HKD 0.132, reflecting a 15% growth year-over-year[23]. Dividends and Shareholder Returns - The company declared an interim dividend of HKD 0.014 per share, up from HKD 0.013 per share in the previous interim period[3]. - The company declared an interim dividend of HKD 1.4 per share, compared to HKD 1.3 per share in the previous interim period[20]. - The company repurchased approximately HKD 6,000,000 worth of its shares during the interim period[56]. Financial Position and Liabilities - The net asset value as of September 30, 2023, was HKD 3,148,498,000, compared to HKD 3,100,590,000 as of March 31, 2023, reflecting an increase of 1.5%[9]. - The company reported a net current liability of HKD 19,196,000 as of September 30, 2023, but maintains that it can meet its obligations based on expected cash flows[11]. - Total liabilities reported were HKD 3,454,434, down 5.3% from HKD 3,647,261[15]. - The company's total liabilities included bank loans of HKD 36,083,000 and lease liabilities of HKD 75,764,000 as of September 30, 2023[9]. - The company did not comply with certain financial covenants related to bank loans, with an outstanding loan amount of approximately HKD 100,335,000[29]. Operational Performance - Operating profit in mainland China grew by 44% in local currency terms, achieving an operating margin of 10%[3]. - The Hong Kong business showed solid performance with a 22% increase in operating profit when excluding prior year subsidies[3]. - Revenue and profitability in Australia and New Zealand were impacted by short-term production and logistics issues[3]. - Tofu export sales in Singapore increased, offsetting intense competition in local tofu products and beverages[3]. - The company aims to enhance sales execution and restore revenue growth while controlling costs and improving operational efficiency in the second half of the fiscal year[50]. Future Outlook and Strategy - The company plans to continue its focus on sustainable development and improving product and packaging offerings, with key performance indicators to be reported in the upcoming sustainability report[43]. - The company remains confident in the growth potential of plant-based products in mainland China and plans to focus on core products and regions to improve profitability[51]. - In Hong Kong, the company will implement product innovation and strengthen core products for sustainable growth[52]. - The company plans to improve tofu business performance in Singapore and advance cost rationalization efforts[53]. Miscellaneous - The company has not applied any new standards or interpretations that have not yet come into effect during the current accounting period[12]. - The interim report will be published on the Hong Kong Stock Exchange website and the company's website shortly[57].

Financial Performance - Vitasoy Group's revenue for FY2022/2023 decreased by 2% to HK$6,341 million compared to HK$6,501 million in the previous year[9]. - The profit attributable to shareholders was HK$46 million, a significant recovery from a loss of HK$159 million in the previous year[16]. - EBITDA increased by 82% to HK$621 million from HK$340 million in the previous year[9]. - Total assets decreased by 14% to HK$5,850 million from HK$6,807 million in the previous year[12]. - Net debt balance improved by 15% to HK$197 million from HK$232 million in the previous year[12]. - Total equity attributable to shareholders decreased by 8% to HK$2,985 million from HK$3,258 million in the previous year[12]. - Basic earnings per share improved to 4.3 HK cents from a loss of 14.9 HK cents in the previous year[9]. - Profit from operations reached HK$104 million, a significant recovery from a loss of HK$213 million in the previous year, despite rising raw material and utility costs[24]. - Profit before taxation was HK$49 million, recovering from a loss of HK$236 million last year[41]. - Gross profit for the year was HK$3,012 million, a decrease of 2% from HK$3,071 million in the previous year, with a gross profit margin increasing to 48% from 47%[33]. Dividend and Shareholder Returns - The Board of Directors recommended a final dividend of HK1.4 cents per ordinary share, bringing the total dividend for FY2022/2023 to HK2.7 cents per ordinary share[16]. - The total dividend for FY2022/2023 is proposed at HK$2.7 per share, comprising a final dividend of HK$1.4 cents and an interim dividend of HK$1.3 cents[18]. - The company intends to declare dividends aligned with profit fluctuations, potentially including special dividends in addition to interim or final dividends[196]. - The company is committed to sharing success with shareholders while considering liquidity and capital requirements in its dividend decisions[196]. Market Performance and Strategy - Sales analysis indicated that 34% of revenue came from Hong Kong operations, while Australia and New Zealand contributed 9%[13]. - The company experienced a 2% revenue increase net of currency impact despite rising input costs and utility expenses[16]. - Group revenue decreased by 2% in Hong Kong dollar terms but increased by 2% net of currency impact, driven by effective cost rationalization and higher government subsidies[24]. - In Mainland China, revenue declined by 2% in local currency, while profit from operations showed growth, indicating stabilization in the market[19]. - The Hong Kong SAR experienced double-digit growth in both revenue and profit from operations due to the easing of pandemic restrictions and strong consumer acceptance of innovations[19]. - Revenue in Australia and New Zealand grew by 3% in local currency, supported by the Oat Milk line and new plant-based Greek Style Yoghurt[19]. - Singapore's revenue faced challenges due to the commoditization of the tofu category, while the Philippines saw strong growth across all platforms and channels[19]. - The company plans to enhance its core VITASOY and VITA brand portfolio in Mainland China through new marketing campaigns and strategic innovations[20]. - In ASEAN markets, the company aims to improve tofu performance and scale up beverage sales, particularly in Singapore and the Philippines[20]. Cost Management and Efficiency - Total operating expenses decreased by 11% to HK$3,022 million from HK$3,409 million in FY2021/2022[37]. - Marketing, selling, and distribution expenses decreased by 9% to HK$2,024 million from HK$2,215 million in FY2021/2022[37]. - Other operating expenses decreased by 34% to HK$326 million from HK$492 million in FY2021/2022[37]. - Administrative expenses decreased by 4% to HK$672 million from HK$702 million in FY2021/2022[37]. - COVID-19 related government subsidies increased to HK$65 million from HK$20 million in FY2021/2022[38]. Corporate Governance and Compliance - The company has complied with the Corporate Governance Code throughout the year ended March 31, 2023[72]. - The Board of Directors is responsible for the overall management of the company and has established various committees for specialized functions[76]. - The company emphasizes the alignment of its culture with business strategies and regularly reviews its core values and ethics policies[73]. - The company has adopted a Corporate Governance Policy, revised in March 2022, to align interests of shareholders and stakeholders[130]. - The status of compliance with the Corporate Governance Code was reviewed, ensuring transparency in disclosures[127]. - The Company has established a Group Business Ethics Policy to enforce ethical standards among employees, with zero tolerance for violations[129]. Risk Management - The Board acknowledges its responsibility for risk management and internal control systems, which are designed to manage rather than eliminate business risks[164]. - The internal control system is based on the COSO components and aims to provide reasonable assurance regarding the safeguarding of assets and the accuracy of financial reporting[167]. - The risk management framework includes ongoing monitoring and oversight to proactively identify and manage risks across the Company[175]. - The risk governance structure consists of three layers: oversight by the Audit Committee, risk monitoring by the Enterprise Risk Management Executive Committee, and risk ownership by department heads[179]. - The risk management process involves anticipating, evaluating, responding, reacting, and reporting on risks, ensuring comprehensive risk management integration into daily operations[180][182]. Sustainability and ESG Initiatives - The company received an "A" grade in the MSCI ESG ratings and was listed in the Corporate Knights' Global 100 Most Sustainable Corporations for the fourth consecutive year[28]. - Vitasoy International Singapore became a Certified B Corporation™ in January 2023, enhancing its commitment to social and environmental performance[28]. - The Group's 2022/2023 Sustainability Report was reviewed and approved, highlighting the company's commitment to sustainability[135]. - The company aims to achieve a set of external sustainability targets under its Sustainability Framework by FY2025/2026[135]. - The company is focusing on decarbonation pathways and has provided strategic direction on its progress in various external ESG ratings[135]. Board Composition and Diversity - Five out of eleven directors are Independent Non-executive Directors (INEDs), exceeding the requirement for INEDs to make up at least one third of the Board[89]. - The Board has adopted a Board Diversity Policy to achieve diversity through factors such as experience, professional qualification, knowledge, gender, ethnicity, and age[94]. - Female representation on the Board during FY2022/2023 was 18.2%, achieving the target of "not less than 18%" set for FY2024/2025[98]. - The Remuneration and Nomination Committee has established measurable objectives for achieving gender and age diversity up to FY2024/2025 and has approved new objectives for FY2029/2030[97]. Training and Development - The average training hours for Directors during FY2022/2023 was 50 hours[148]. - Senior Management averaged 67 hours of training during the same period[153]. - The Company organized an annual in-house training program in August 2022 focusing on general disclosure obligations and key considerations for transactions[149]. - The training program for Directors included topics such as governance, innovation, and technology[150]. - The Company encourages continuous professional development for both Directors and Senior Management[153].

Financial Performance - For the fiscal year 2022/2023, the company achieved a revenue growth of 2% after excluding foreign exchange effects, although revenue decreased by 2% in HKD terms due to the depreciation of RMB and AUD [2]. - The operating profit for the year was HKD 104 million, a significant recovery from a loss of HKD 213 million in the previous year, attributed to effective cost control and increased government subsidies in Hong Kong [2]. - The gross profit for the year was HKD 3,012 million, a decrease of 2%, while the gross profit margin improved from 47% to 48% [2]. - EBITDA increased by HKD 281 million or 82% to HKD 621 million, with the EBITDA margin rising from 5% to 10% [2]. - The profit attributable to equity holders of the company was HKD 46 million, compared to a loss of HKD 159 million in the previous year, aligning with the profit forecast announced on May 19, 2023 [2]. - Total revenue for the year ended March 31, 2023, was HKD 6,340,559,000, a decrease from HKD 6,501,215,000 in the previous year, representing a decline of approximately 2.5% [13]. - Revenue from Mainland China for the year was HKD 3,509,101,000, down from HKD 3,838,297,000, reflecting a decrease of about 8.6% [13]. - Revenue from Hong Kong operations increased to HKD 2,143,815,000 from HKD 1,933,856,000, marking an increase of approximately 10.8% [13]. - The company experienced a net loss of HKD 340,309,000 from its Mainland China operations, compared to a profit of HKD 45,918,000 in the previous year [13]. - The company reported a pre-tax profit of HKD 325,641,000 in 2023, compared to HKD 492,162,000 in 2022, reflecting a decrease of about 34% [18]. Dividends - The total dividend for the fiscal year 2022/2023 is HKD 2.7 cents per share, compared to no dividends in the previous fiscal year [2]. - The board proposed a final dividend of HKD 0.014 per share, resulting in a total annual dividend of HKD 0.027 per share for the fiscal year 2022/2023 [34]. - The company declared an interim dividend of 1.3 HK cents per ordinary share for 2023, totaling 13,916,000 HKD, compared to no dividend in 2022 [21]. - The proposed final dividend of 1.4 HK cents per ordinary share is expected to amount to 15,009,000 HKD, also compared to no dividend in 2022 [21]. Acquisitions and Investments - The company completed the acquisition of the remaining 49% stake in Vitasoy Australia Products Pty. Ltd. in February 2023 [2]. - The company acquired the remaining 49% stake in Vitasoy Australia Products Pty. Ltd. for 51,000,000 AUD (approximately 280,345,000 HKD), increasing its ownership to 100% [32]. Operational Challenges and Strategies - The company faced weak commercialization and export of tofu products in Singapore, impacting its business there [2]. - The company plans to enhance its tofu product performance and launch new plant-based milk products to accelerate beverage sales in Singapore and the Philippines [36]. - In Australia and New Zealand, the company aims to solidify its leadership in the plant milk sector and further develop new plant-based yogurt products [36]. - Revenue in Singapore decreased by 11% due to the commoditization of tofu products and weak overseas demand [49]. Financial Position and Liquidity - The net current liabilities decreased from HKD 475,424 thousand to HKD 275,637 thousand, indicating improved liquidity [6]. - The company had cash and bank deposits of HKD 555,292,000 as of March 31, 2023, which is crucial for meeting its current liabilities [8]. - The company’s cash and bank deposits as of March 31, 2023, were HKD 555,000,000, down from HKD 622,000,000 a year earlier [54]. - Total assets reported were HKD 7,585,390,000, down from HKD 8,227,692,000, reflecting a decrease of approximately 7.8% [13]. - Total assets decreased from HKD 6,807,120,000 in 2022 to HKD 5,849,519,000 in 2023, reflecting a reduction of approximately 14% [14]. - Total liabilities decreased from HKD 3,238,021,000 in 2022 to HKD 2,748,929,000 in 2023, a decline of about 15% [14]. - The debt-to-equity ratio decreased to 25% from 26% in the previous year [54]. Government Support and Grants - Government grants received in 2023 amounted to HKD 64,397,000, down from HKD 77,060,000 in 2022, representing a decrease of approximately 16% [15]. - The company received COVID-19 related government subsidies of HKD 65 million during the fiscal year, up from HKD 20 million in the previous year [41]. Risk Management and Compliance - The group emphasizes the importance of corporate and social responsibility in its tax strategy, ensuring compliance with tax laws in all relevant jurisdictions [56]. - The overall financial management policy focuses on forecasting and controlling risks, implementing a centralized cash and financial management system for all subsidiaries [57]. - A comprehensive risk management framework is in place to predict, assess, and mitigate key business risks, with enhanced key risk indicators to identify emerging external risks [58]. - The audit committee, consisting of four independent non-executive directors, has reviewed the group's accounting principles and discussed audit, risk management, and financial reporting matters [59]. Future Outlook - The company plans to focus on expanding its market presence and enhancing product offerings in the upcoming fiscal year [8]. - The company remains confident in its long-term profitability growth trajectory, focusing on innovative product development and market expansion strategies [36].

Financial Performance - Revenue for the six months ended September 30, 2022, was HK$3,642 million, a 1% increase from HK$3,604 million in the same period of 2021[8]. - Gross profit for the same period was HK$1,738 million, reflecting a 1% increase from HK$1,727 million[8]. - EBITDA increased by 48% to HK$473 million, up from HK$320 million[8]. - Profit attributable to equity shareholders surged by 332% to HK$142 million, compared to HK$33 million in the previous year[8]. - Basic earnings per share rose to 13.3 HK cents, a 329% increase from 3.1 HK cents[8]. - The Group's revenue for the interim period increased by 1% to HK$3,642 million, compared to HK$3,604 million in the previous interim period[26]. - The Group's gross profit for the interim period was HK$1,738 million, up 1% from HK$1,727 million in the previous interim period[28]. - Profit before taxation surged over 400% to HK$175 million, compared to HK$34 million in the previous interim period[33][36]. - The Group reported a profit attributable to equity shareholders of $141,801,000 for the interim period, a significant increase from $32,804,000 in the previous interim period[138][141]. Revenue by Region - In Mainland China, revenue grew by 4% in local currency despite ongoing pandemic impacts[14]. - Hong Kong operations saw a revenue growth of 6%, supported by successful product innovations[16]. - Australia and New Zealand experienced an 8% revenue increase, driven by consumer interest in oat milk and the launch of new products[17]. - Singapore's revenue contracted by 16% in local currency, resulting in an operating loss due to market challenges[18]. - The Philippines joint venture with URC achieved double-digit revenue gains, capturing a 14% market share in the plant milk category[19]. - Revenue from external customers in Mainland China decreased by 1% to HK$2,216 million, while profit from operations improved to HK$139 million from a loss of HK$33 million in the previous year[50][51]. - Revenue in local currency terms grew by 4% to RMB1,916 million, driven by strong growth in operating profit due to scale acceleration and tight control over operating costs[50][55]. - Revenue from Hong Kong operations (including Hong Kong SAR, Macau SAR, and exports) grew by 6%, driven by strong core business and successful product innovations[22]. - In Australia and New Zealand, revenue increased by 8% in local currency, attributed to strong performance in the VITASOY Oat Milk portfolio[26]. Operating Expenses and Profitability - Total operating expenses decreased by 9% to HK$1,588 million, compared to HK$1,737 million in the previous interim period[28]. - Marketing, selling, and distribution expenses decreased by 10% to HK$1,068 million, reflecting rephased advertising and promotion spending[28]. - The gross profit margin was maintained at 48%, consistent with the previous interim period, due to higher sales volume and lower trade promotional expenses[28]. - The Group's profit attributable to equity holders increased by over 300%, with adjusted profit showing a 187% improvement excluding COVID-19 related government subsidies[23]. Cash Flow and Liquidity - As of 30th September 2022, cash and bank deposits amounted to HK$898 million, up from HK$622 million as of 31st March 2022[40]. - The Group's net cash balance was HK$80 million, a significant improvement from a net debt balance of HK$232 million as of 31st March 2022[40]. - Cash generated from operations for the six months ended September 30, 2022 was HK$516,743,000, significantly higher than HK$277,131,000 in the previous year, indicating an increase of about 86.5%[95]. - The net cash generated from operating activities was HK$494,425,000, compared to HK$274,128,000 in the prior year, reflecting a growth of approximately 80.4%[95]. - The company had cash and cash equivalents of HK$897,800,000 as of 30th September 2022, an increase from HK$799,453,000 at the same time in 2021[96]. - The company incurred net cash used in investing activities of HK$112,557,000, a decrease from HK$230,484,000 in the prior year, indicating improved cash management[95]. Dividends and Shareholder Returns - An interim dividend of HK1.3 cents per ordinary share was declared for the interim period, compared to nil in the previous interim period[25]. - The Company declared an interim dividend of HK$1.3 cents per ordinary share for the interim period, compared to nil in the previous interim period[193]. - The Register of Members will be closed on December 6, 2022, for shareholders to qualify for the interim dividend, with all transfers needing to be lodged by December 5, 2022[194]. Employee and Community Engagement - Approximately 46,501 hours were spent on learning and development activities by employees during the interim period[71]. - The total number of employees worldwide as of September 30, 2022, was 6,869[71]. - The company supported a school nutrition program benefiting approximately 5,000 rural children across 35 primary schools in various provinces in Mainland China[74]. - An interactive online education program focusing on plant-based nutrition reached 25,000 children aged 6 to 16 in Hong Kong SAR[78]. - The company continued to drive community programs under the theme "Nourish Your Body, Nourish Your Mind" to promote health awareness[73]. Capital Expenditure and Assets - Capital expenditure during the interim period decreased to HK$77 million from HK$95 million in the previous interim period, primarily for normal maintenance and upgrades[41][45]. - The total consolidated assets as of September 30, 2022, were HKD 6,420,399,000, down from HKD 6,807,120,000 as of March 31, 2022, reflecting a decrease of approximately 5.7%[127]. - The Group's reportable segment assets as of September 30, 2022, totaled HKD 7,677,659,000, down from HKD 8,227,692,000 as of March 31, 2022, representing a decrease of about 6.7%[122]. Share Capital and Equity - The total number of ordinary shares issued by the Company as of September 30, 2022, was 1,070,801,035[196]. - The amount of share capital increased to $1,019,760,000 as of 30th September 2022, up from $1,013,028,000 at 31st March 2022[163]. - The company held 367,000 treasury shares as of 30th September 2022, down from 500,000 shares at 31st March 2022[167]. - The total number of options granted during the six months ended 30th September 2022 was 3,428,000, compared to 2,704,000 in the previous year[176]. Joint Ventures and Acquisitions - Vita International Holdings Limited plans to acquire the remaining 49% of Vitasoy Australia Products Pty. Ltd. for AUD27,500,000 (approximately HK$137,500,000), with the acquisition expected to close around the end of January 2023[189]. - Sales to the joint venture in the Philippines for the interim period totaled HK$12,283,000, an increase of 55.5% compared to HK$7,902,000 in the previous interim period[187]. - The amount due from the joint venture as of September 30, 2022, was HK$8,923,000, up from HK$4,919,000 as of March 31, 2022, representing an increase of approximately 81.5%[187].

Financial Performance - Vitasoy's revenue for FY2021/2022 decreased by 14% to HK$6,501 million compared to HK$7,520 million in the previous year[21]. - The gross profit for the same period was HK$3,071 million, down 22% from HK$3,954 million[10]. - EBITDA fell significantly by 73% to HK$340 million from HK$1,281 million year-on-year[10]. - The loss attributable to equity shareholders was HK$159 million, a decline from a profit of HK$548 million in the previous year[21]. - Total assets decreased by 6% to HK$6,807 million from HK$7,276 million[15]. - Total equity attributable to equity shareholders dropped by 10% to HK$3,258 million from HK$3,616 million[15]. - The company did not recommend a final dividend for FY2021/2022, marking a 100% reduction from the previous year's dividend of HK$32.8 cents per share[10]. - The loss from operations was HK$213 million, a decline from last year's profit of HK$843 million, attributed to weaker sales in Mainland China and reduced COVID-19 subsidies[33]. - COVID-19 related government subsidies fell from HK$225 million in FY2020/2021 to HK$20 million in FY2021/2022, impacting overall profitability[33]. - Loss before taxation was HK$236 million, compared to a profit before taxation of HK$767 million last year[56]. - Cash and bank deposits amounted to HK$622 million, a decrease from HK$971 million as of March 31, 2021[59]. - The Group's total debt increased to HK$854 million, with bank borrowings rising to HK$490 million from HK$130 million the previous year[60]. - The gearing ratio increased to 26%, up from 14% in the previous year, reflecting a 12 percentage point rise[41]. - ROCE (Return on Capital Employed) dropped to 9%, down from 34% in the previous year, representing a decline of 25 percentage points[41]. Market Performance - In Mainland China, the company faced challenges due to the COVID-19 pandemic but saw improved performance in the second half of FY2021/2022 compared to the first half[22]. - Group revenues declined by 14% for the full Financial Year due to weak sales in Mainland China, despite solid growth in other markets such as Hong Kong SAR, Australia, New Zealand, and Singapore[32]. - Mainland China revenue declined by 23%, with a 28% decrease in local currency, although a strong recovery was noted in the second half of FY2021/2022[43]. - Hong Kong operations saw a revenue increase of 4%, driven by innovative products despite intermittent school openings[45]. - Australia and New Zealand experienced a 15% revenue growth, supported by the expansion of the Oat Milk portfolio as restrictions eased[45]. - Revenue from external customers in Mainland China declined by 28% in local currency and 23% in HKD terms, resulting in an operating loss of RMB280 million compared to a profit of RMB457 million in the previous year[75][76]. - Net sales revenue in Hong Kong reached HK$1,934 million, representing a growth of 4% over the previous year, despite challenges from COVID-19 restrictions[80][82]. - Singapore's revenue from external customers grew by 3% to HK$122,091 thousand, while the operating loss was SGD2,198,000, down from a profit of SGD529,000 in the previous year[89][90]. Strategic Initiatives - The company is prioritizing business recovery following the challenging operating environment[21]. - New product launches such as VITAOAT and VITA Fresh Tea received strong consumer acceptance in Hong Kong, aiding recovery[22]. - The company is focusing on core portfolio execution and strategic innovation to gradually restore growth trajectory[29]. - To counter rising material costs, the company is taking selective pricing actions and locking in raw material prices in procurement contracts[34]. - The company is committed to innovation, aiming to bring new products to market that appeal to different consumer segments[34]. - For FY2022/2023, the company aims to restore year-on-year profitable growth through execution, expansion, and innovation strategies[93]. - New brand equity campaigns will be launched for VITASOY and VITA in Mainland China, alongside continued innovation in existing product lines[94][96]. - The company plans to selectively expand product availability in high-potential areas of Mainland China[96]. - The joint venture in the Philippines focuses on building brand awareness and adoption, with plans to activate single-serve platforms post-COVID-19 restrictions[98]. - The plant-based movement presents a unique opportunity for Vitasoy to expand its mission of providing nutritious plant-based food and beverages[100]. Corporate Governance - Vitasoy's corporate governance practices emphasize transparency, independence, and accountability, with regular reviews to enhance compliance[105]. - The Board of Directors includes five independent non-executive directors, ensuring diverse knowledge and skills[107]. - The company achieved a 99% average attendance rate at Board meetings during FY2021/2022[108]. - Vitasoy has complied with the amended Corporate Governance Code, implementing key compliance enhancement initiatives[110]. - The company has established a defined schedule of matters reserved for Board decisions, ensuring accountability and compliance with regulatory requirements[127]. - The governance framework is regularly reviewed to maintain its effectiveness[143]. - The Company has established a Remuneration and Nomination Committee, an Audit Committee, an Executive Committee, and an ESG Committee[176]. - The Board ensures compliance with good corporate governance practices and promotes a culture of accountability and integrity[165]. - The Company actively engages with stakeholders to ensure effective communication and promote corporate culture[165]. Risk Management and Compliance - The Group's risk management framework has been enhanced to address emerging risks and improve key risk indicators in a rapidly changing business environment[71][72]. - The Company monitors and reviews the effectiveness of its risk management performance regularly[168]. - The Audit Committee is responsible for monitoring the implementation and effectiveness of the Whistleblowing Policy[198]. - The Company is committed to maintaining effective internal controls and compliance with legal and regulatory requirements[197]. - The Company reviewed compliance with the Corporate Governance Code and related disclosures[197]. Sustainability and ESG - The Environmental, Social and Governance (ESG) performance continues to improve, as evidenced by better external ratings[26]. - The company is committed to accelerating its performance in Environmental, Social, and Governance (ESG) deliverables[100]. - Vitasoy's commitment to sustainability is integrated into its corporate philosophy, guiding its operations and product development[116].

Financial Performance - Revenue decreased by 18% to HK$3,604 million compared to HK$4,410 million in the previous year[11] - Profit attributable to equity shareholders dropped by 95% to HK$33 million from HK$672 million[11] - Gross profit fell by 28% to HK$1,727 million, down from HK$2,410 million[11] - EBITDA decreased by 72% to HK$320 million, compared to HK$1,152 million in the prior year[11] - Basic earnings per share plummeted by 95% to 3.1 HK cents from 63.1 HK cents[11] - Profit from operations dropped by 95%, primarily due to a significant decline in sales in Mainland China[14] - Profit before taxation decreased by 96% to HK$34 million, down from HK$916 million in the same period last year[18] - Profit for the period was HKD 40,975, a significant decline of 94.1% compared to HKD 699,560 in the prior year[51] - Total comprehensive income for the period was HKD 63,021,000, down from HKD 845,324,000, indicating a decrease of about 93% year-over-year[54] Assets and Liabilities - Total assets declined by 5% to HK$6,885 million from HK$7,276 million[11] - Total equity attributable to equity shareholders fell by 6% to HK$3,384 million from HK$3,616 million[11] - The Group's net cash balance decreased to HK$81 million from HK$453 million, while available banking facilities amounted to HK$894 million[20] - Current assets totaled HKD 2,681,077,000, a decrease from HKD 2,969,750,000 as of March 31, 2021, representing a reduction of about 10%[57] - Current liabilities amounted to HKD 2,983,051,000, down from HKD 3,083,974,000, indicating a decrease of approximately 3%[57] - Net current liabilities increased to HKD (301,974,000) from HKD (114,224,000), showing a deterioration in liquidity position[57] Sales and Market Performance - The reduction in sales was attributed to decreased government pandemic-related subsidies and increased advertising spending[3] - Revenue from external customers in Mainland China declined by 29% to HK$2,230 million, primarily due to sales disruption during the peak summer months[24] - Hong Kong operations saw a revenue increase of 3% despite ongoing COVID-19 disruptions[15] - Australia and New Zealand revenue grew by 27% (17% in local currency), driven by successful innovations in the Oat Milk portfolio[15] - Revenue in RMB terms from external customers in Mainland China dropped 35%, reflecting the impact of product availability during the peak season[24] Operational Changes and Strategies - The company remains confident about the recovery of its Mainland China business and upcoming product innovations[4] - The company has implemented a program to accelerate sales recovery in Mainland China through new product launches[14] - The company plans to strengthen in-store activations and promotional activities in the second half to accelerate recovery and restore growth in the new fiscal year[26] - The Group plans to accelerate advertising and in-store activities in Mainland China to drive growth for its core portfolio and new products, including VITAOAT Oat Milk and VITA Sparkling Lemon Tea[38] Employee and Community Engagement - As of September 30, 2021, over 82% of full-time employees have been vaccinated, with a total of 7,166 employees worldwide[40] - The Group provided approximately 46,118 training hours to its employees worldwide during the first six months of FY2021/2022[41] - Community efforts in the Philippines included supplying products to local government entities and NGOs to support community pantries during the COVID-19 pandemic[42] - In Mainland China, the Group supported nutrition education in 100 schools across 10 cities, highlighting the health benefits of soy and soymilk[43] Dividends and Shareholder Returns - The board has not declared an interim dividend for the six months ended 30th September 2021 due to disappointing results[14] - The total amount of final dividends approved and paid during the interim period was $310,158,000, an increase of 2.8% from $302,325,000 in 2020[160] - The interim dividend declared for the previous financial year was 29.0 cents per ordinary share, compared to 28.4 cents per ordinary share for the same period in 2020[160] Segment Performance - The Group operates four reportable segments: Mainland China, Hong Kong (including Macau and Exports), Australia and New Zealand, and Singapore, focusing on the manufacture and sale of soya milk and related products[86] - Reportable segment revenue decreased to HK$3,667,218,000 for the six months ended September 30, 2021, down from HK$4,470,034,000 in the same period of 2020, representing a decline of approximately 18%[99] - Profit from operations for reportable segments showed a loss of HK$123,003,000 in 2021, compared to a profit of HK$986,255,000 in 2020, indicating a significant decrease in operational performance[98] Financial Management and Compliance - The interim financial report is unaudited but has been reviewed by KPMG, ensuring compliance with Hong Kong accounting standards[76] - The Group's accounting policies remain consistent with those adopted in the 2020/2021 annual financial statements, except for new amendments[78] - The Group has not adopted any new accounting standards that are not yet effective for the current accounting period[82] Shareholder Information - The total number of ordinary shares issued by the company is 1,070,009,500 as of September 30, 2021[200] - Mr. Winston Yau-lai LO holds 166,820,600 shares, representing 15.59% of the total issued shares[200] - Mr. Peter Tak-shing LO has 130,855,000 shares, accounting for 12.23% of the total issued shares[200] - Ms. Yvonne Mo-ling LO owns 92,084,750 shares, which is 8.61% of the total issued shares[200]

Financial Performance - Revenue for the year ended March 31, 2021, was HK$7,520 million, representing a 4% increase from HK$7,233 million in 2020[8] - Gross profit increased by 3% to HK$3,954 million in 2021, compared to HK$3,851 million in the previous year[8] - EBITDA for the year was HK$1,281 million, a significant increase of 17% from HK$1,097 million in 2020[8] - Profit attributable to equity shareholders rose by 2% to HK$548 million, up from HK$536 million in 2020[8] - Basic earnings per share increased to 51.5 HK cents, a 2% rise from 50.4 HK cents in the previous year[8] - Total dividends per ordinary share were 32.8 HK cents, slightly up from 32.2 HK cents in 2020, marking a 2% increase[8] - For FY2020/2021, Vitasoy Group's revenue grew by 4% to HK$7,520 million, while profit attributable to equity shareholders increased by 2% to HK$548 million[20] - Total assets as of March 31, 2021, were HK$7,276 million, representing a 14% increase from HK$6,410 million in 2020[16] - The net cash balance increased by 25% to HK$453 million, up from HK$363 million in the previous year[16] - Total equity attributable to shareholders rose by 16% to HK$3,616 million, compared to HK$3,128 million in 2020[16] - Operating profit rose by 19% compared to FY2019/2020, but would have declined by 11% without COVID-19-related government subsidies of HK$225 million[26] - Profit before taxation increased by 13% to HK$767 million compared to HK$679 million in the previous fiscal year[41] - Profit attributable to equity shareholders of the Company was HK$548 million, representing a 2% increase from HK$536 million, but a 35% decrease when excluding COVID-19-related government subsidies[41] Market and Product Development - The company plans to continue expanding its market presence and product offerings in the upcoming fiscal year[3] - New product development initiatives are underway to enhance the product portfolio and meet consumer demand[3] - The company is exploring potential acquisitions to strengthen its market position and drive growth[3] - Future guidance indicates a focus on sustainable growth and innovation in product development[3] - Vitasoy Group plans to continue investing in infrastructure and brand equity to secure long-term growth as plant-based food becomes more mainstream[21] - A new high-calcium low-sugar oat milk product was introduced to enhance the plant milk offering[52] - The company plans to relaunch its domestic tofu business in Singapore and expand its imported beverage portfolio[67] - In the Philippines, the joint venture with Universal Robina Corporation will focus on establishing the VITASOY brand while launching a new campaign for single-serve products[68] Regional Performance - Revenue from the Hong Kong operation fell by 12% due to COVID-19 restrictions impacting on-the-go and on-premise channels[21] - Revenue in Mainland China grew by 8% in local currency terms, leading the Group's overall recovery[21] - Australia and New Zealand revenue decreased by 1% in local currency, with recovery noted in the second half of the year[21] - Singapore revenue remained flat, affected by declines in beverage and export businesses[21] - Mainland China revenue grew by 8% in local currency and 11% in HKD, while Hong Kong operations saw a decline of 12%[33] - In Australia and New Zealand, revenue fell by 1% in local currency, with profit from operations dropping 16% due to high raw material prices and increased investments[55] - Singapore's revenue remained flat in local currency, but profit from operations dropped by 39% due to increased staff costs and delayed innovations[57] Governance and Corporate Structure - The Board of Directors consists of 11 members, with 5 independent non-executive directors and 2 female directors, ensuring a diverse mix of knowledge and expertise[88] - The average attendance rate for Board meetings was 97% during FY2020/2021, reflecting strong governance practices[88] - The Company has established various committees to carry out specialized functions assigned by the Board of Directors[92] - The Board is responsible for developing strategic directions and continuous monitoring of the Company's performance[94] - The Board has approved a Five Year Strategic Plan for the fiscal years up to 2025/2026, focusing on proactive reviews in response to macroeconomic changes[95] - The number of Independent Non-executive Directors is nearly half of the total Board members, exceeding the Listing Rules requirement of at least one third[98] - Female representation on the Board during the year 2020/2021 was 18.2%, achieving the target of "not less than 18%" set for the years up to 2024/2025[110] - The average age of Board members during the year 2020/2021 was 66, meeting the target of "average 67-70" set for the years up to 2024/2025[112] - The Company has established measurable objectives for achieving gender and age diversity up to the year of 2024/2025[107] - The Board Diversity Policy was adopted in June 2013 to enhance the quality of performance through diverse Board composition[106] Sustainability and ESG Initiatives - Vitasoy's ESG rating was upgraded from "BBB" to "A" by Morgan Stanley Capital International, reflecting improvements in sustainability practices[29] - The company ranked 62nd in the 2021 Corporate Knights Global 100 Most Sustainable Corporations, improving from 90th the previous year[74] - The company has been awarded the "Outstanding Energy-saving Enterprise in China Beverage Industry 2020" by the China Beverage Industry Association[78] - The Board approved several key policies including the Diversity and Inclusion Policy and the Zero Deforestation Policy to enhance sustainability efforts[154] - The ESG Committee was established to oversee sustainability issues and provide strategic guidance on ESG performance and goals[155] - The Company reviewed public policies and peer approaches on packaging waste, aiming to mitigate environmental impact[154] - The Company has committed to reducing resource usage through the Waste Management Policy and Water Stewardship Policy[155] - The Company’s commitment to anti-discrimination and anti-harassment is reinforced through its policies aimed at fostering a diverse workforce[155] Risk Management and Internal Controls - The internal control system is based on COSO components and aims to manage and mitigate business risks rather than eliminate them[194] - The internal control system is designed to ensure assets are safeguarded, business activities are efficient, financial reporting is accurate, and compliance with laws is maintained[197] - The Board is responsible for overseeing the effectiveness of the internal control system, while management is tasked with its design and implementation[197] - The Group Internal Audit plays a critical role in monitoring the internal governance of the Company, ensuring effective risk management functions and controls in business operations[198] - The annual audit plan is prepared using risk assessment methodology, focusing on areas with higher risk, and is reviewed and approved by the Audit Committee[199] - The effectiveness of internal control over operational, compliance, and financial reporting is regularly reviewed to mitigate risks[198]